Ads
related to: spiriva manufacturer patient assistance program- Efficacy
See efficacy and clinical study
information for SPIRIVA RESPIMAT.
- Inhaler Administration
Discover information on RESPIMAT
and how to use the inhaler.
- Real-World Evidence
Why does inhaler choice
matter to patients?
- Safety Profile
See safety profile information
from across clinical trials.
- Efficacy
Search results
Results from the WOW.Com Content Network
Pharmaceutical manufacturer patient assistance programs (PAPs) PAP programs help people on a low income to pay for their out-of-pocket drug costs. Pharmaceutical companies operate these programs.
Tiotropium bromide, sold under the brand name Spiriva among others, is a long-acting bronchodilator (LAMA: long acting muscarinic antagonist) used in the management of chronic obstructive pulmonary disease (COPD) and asthma.
The insurance benefit manager recognizes the drug as a TIER 3 brand for the patient and relays the patient co-pay to be $30.00. The co-pay card benefit manager recognizes the $30.00 and covers the $20.00 of co-pay, leaving $10 for the patient to pay out of pocket. Another patient without prescription insurance coverage follows the same process.
Specialty drugs patient care management is meant to be both high technology and high touch care, or patient-centered care with "more face-to-face time, more personal connections". Patient-centered care is defined by the Institute of Medicine as "care that is respectful of and responsive to individual patient preferences, needs and values". [27]
For premium support please call: 800-290-4726 more ways to reach us
Individuals with Medicare Part D who use Restasis may be eligible for myAbbVie Assist and other prescription cost support. Learn more here.
The Medicaid Drug Rebate Program provides for mandatory rebates on innovator drugs (e.g., brand drugs), blood clotting factors, drugs Food and Drug Administration-approved exclusively for pediatric indications, and non-innovator drugs (e.g., generic drugs). [1] The maximum rebate is capped at 100% of the Average Manufacturer Price (AMP).
Gallup reported the percentage of population uninsured throughout 2016 in states that expanded and did not expand Medicaid. For comparison, we added 2013 percentages for each state.
Ads
related to: spiriva manufacturer patient assistance program